Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Net Asset Value Estimate/ Progress on Realisations

25 Jan 2017 07:00

RNS Number : 0186V
LMS Capital PLC
25 January 2017
 

25 January 2017

 

LMS Capital plc

 

Net Asset Value Estimate and Progress on Realisations

 

 

LMS Capital plc (the "Company") is a listed Investment Company focused on investing directly, and through third party funds, in small to medium size private companies in the UK, Europe and the US. Gresham House Asset Management Ltd ("GHAM") was appointed to manage the investment portfolio in August 2016, alongside a change of mandate from realisation to focused direct private equity investment at the smaller end of the market.

 

Since assuming the investment mandate, significant progress has been made in transitioning to external management and towards achieving target annualised cost savings. GHAM has progressively engaged with the underlying portfolio companies, implementing new investment processes under the guidance of its newly established Investment Committee, with a focus on long term shareholder value creation. GHAM has appointed Tim Farazmand to the Investment Committee. Tim has over 30 years' experience in UK mid-market private equity most recently as Managing Director of Lloyds Development Capital and was also Chairman of the British Venture Capital Association.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third party fund manager valuations. Whilst valuations of the Company's US investments have benefitted from currency movements, performance in some of the Company's investments has deteriorated since June 2016, impacting their respective valuations.

 

As a consequence, the Board currently estimates that the year-end net asset value will be in the region of £67 million (69.5p per share). This estimate is subject to further evaluation and completion of the annual audit. The estimate takes into account the tender offer in September 2016 which returned £6 million to shareholders and incorporates one off costs associated with the transition from being self-managed to an externally managed company. Once complete, this transition is expected to deliver estimated annualised savings of approximately £1 million.

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines and takes account of active sales processes where relevant.

 

Progress on Realisations

 

The Company has concluded an agreement to a two stage sale of one of its US investments. The exit valuation is in line with the NAV as of 30 June 2016. The stage 1 payment of $4.5 million was received on 23 January 2017. The second and final stage will be settled either as a one off payment of $5 million in January 2018 or a loan note repayable with interest in instalments over 4 years.

 

The Company has also agreed the realisation of its holding in a US listed companies fund. The realisation is expected to complete in stages during the first half of 2017. The first stage, representing 35% of the holding, has been completed at a premium to 30 June 2016 NAV and proceeds of $1.3 million have been received. The balance is due to be paid in the second quarter of 2017 and will be determined by the NAV of the fund at the time.

 

Realisations since the circular sent to shareholders on 27 July 2016 have totalled £6.9 million. As set out in the circular, when net realisation proceeds reach £12 million, up to £6 million will be returned to shareholders in a tender offer.

 

The company expects to announce its audited results in mid-March.

 

 

Enquiries:

 

LMS Capital PLC

Martin Knight, Chairman

 

0207 935 3555

 

Gresham House Asset Management

Graham Bird, Investment Director

 

0203 837 6275

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley

 

0207 742 4000

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVZLFLDFFZBBE
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.